Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 May 2026 - 16:30

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/lenalidomide-mylan

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters